A Top Year for Clinical Trial Applications for New Medicines in China
On June 7, 2022, the Center for Drug Evaluation (CDE) of China’s National Medical Products Administration (NMPA) released the Annual Report on Progress of Clinical Trials for New Drug Registration in China (2021). CDE and NMPA’s annual report represents a comprehensive summary and analysis of clinical drug trials for new drugs within the last 3…